NCT03311958 2025-04-06Molecular Monitoring With Circulating Tumor DNA and Nivolumab MaintenanceFox Chase Cancer CenterPhase EARLY_PHASE1 Completed15 enrolled
NCT04890236 2025-01-20Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS StudyEmory UniversityPhase EARLY_PHASE1 Completed4 enrolled
NCT02405078 2022-10-28Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Completed35 enrolled
NCT00424242 2021-09-08Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesNorthwestern UniversityPhase EARLY_PHASE1 Completed15 enrolled
NCT01719250 2018-10-09Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaMayo ClinicPhase EARLY_PHASE1 Completed7 enrolled
NCT00017381 2013-01-09Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase EARLY_PHASE1 Completed30 enrolled